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Background: The biologically active phospholipids Platelet-activating Factor (PAF) and oxidatively
truncated phospholipids from chemical oxidation are increased in the circulation of rats subject to
the oxidant stress of chronic ethanol ingestion. Potentially, circulating inﬂammatory and apoptotic
phospholipids correlate to physiologic oxidative stress.
Results: PAF and the common oxidatively truncated and biologically active phospholipid azelaoyl
phosphatidylcholine (Az-PC) were signiﬁcantly increased in the plasma of older mice, and in male mice.
PAF and Az-PC are very rapidly cleared from the circulation, which was unaffected by age or sex.
Platelets exposed to Az-PC display phosphatidylserine on their surface, and occlusive platelet carotid
arterial thrombosis is enhanced by aging.
Conclusion: Biologically active phospholipids vary in the circulation, with the highest levels being found
in older, male mice. Turnover of PAF and the biologically active Az-PC are rapid and are invariant with
age and sex, so increased production accounts for the increased concentration and ﬂux of both lipids.
Platelets are exposed to plasma Az-PC that depolarizes their mitochondria to increase pro-thrombotic
phosphatidylserine expression, and occlusive platelet thrombosis is enhanced in aged mice.
Signiﬁcance: Oxidatively modiﬁed phospholipids are increased in the circulation during common, mild
oxidant stresses of aging, or in male compared to female animals. Turnover of these biologically active
phospholipids by rapid transport into liver and kidney is unchanged, so circulating levels reﬂect
continuously increased production.
& 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license. Introduction
Polyunsaturated fatty acids esteriﬁed in phospholipids are
susceptible to free radical oxidation that fragments these sn-2
residues to small, and sometimes reactive, fragments from the
distal end of the residue, while leaving the proximal fragment
esteriﬁed in the parent phospholipid. These truncated phospho-
lipids are not products of normal cellular metabolism, and are
both excellent markers of oxidation even in complex in vivo
responses to oxidative injury [1] and are unregulated mediators of
inﬂammation and cell death.er B.V.
ne; PAF, Platelet-activating
ar and Molecular Medicine,
ner College of Medicine,
Open access under CC BY-NC-NFragmentation of esteriﬁed phospholipid (hydro)peroxides gen-
erates phospholipids retaining the proximal fatty acyl fragment,
and because oxidizable polyunsaturated fatty acyl residues are
commonly incorporated into the sn-2 position, phospholipid oxida-
tion produces a large number of oxidized and truncated phospho-
lipids with chemically modiﬁed sn-2 residues. All of these are
membrane disruptive, but many are biologically active because
they stimulate the G protein coupled receptor for the phospholipid
mediator Platelet-activating Factor (PAF), or enter cells to drive
PPARg-controlled gene transcription, or more commonly to depo-
larize mitochondria to initiate cell death through the intrinsic
apoptotic cascade [2].
PAF, and the oxidatively truncated phospholipids, are speciﬁ-
cally hydrolyzed to their component lysophospholipid and fatty
acid fragment by either circulating PAF acetylhydrolase (lipopro-
tein-associated phospholipase A2; PLA2G7) [3,4], or by intracel-
lular PAF acetylhydrolase (PAFAH2) [5]. While a great deal of
attention has focused on PLA2G2 inhibition [6–8], it turns out to
be irrelevant to inactivation of circulating PAF or oxidatively
truncated phospholipids. Inhibition of blood-borne PLA2G7 does
not increase the levels of its substrates in the circulation [9]D license. 
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hydrolysis by this circulating enzyme. Rather, both phospholipids
are removed from circulation with a half life of tens of seconds, so
truncated phospholipids and PAF in plasma reﬂect only a small
portion of what must be a large ﬂux through the circulation.
The level of circulating oxidized phospholipids is increased in
animals exposed to the oxidative stress of chronic ethanol catabo-
lism, but whether this actually results from increased formation
of oxidative phospholipid modiﬁcation or instead reﬂects decreased
removal from the circulation is unknown. The risk of lipid oxidation
and atherosclerosis is increased in human males and in male
animals for incompletely understood reasons, but increased
oxidative stress is a potential effector of this.
We probed for the presence of the abundant oxidized phospho-
lipid Az-PC as a marker for increased oxidative stress as a function of
age and sex because Az-PC is both an abundant phospholipid
oxidation marker, it is also highly effective in depolarizing cellular
mitochondria to disrupt cellular function. We also determined
whether the structurally related lipid mediator PAF was increased
in parallel with Az-PC. PAF is both a remarkably potent and
pleiotropic activator of numerous cells of the innate immune system
[10], but both are cleared by the same endothelial cell TMEM30a
phospholipid importer [11]. We ﬁnd both biologically active phos-
pholipids are increased in vivo as part of normal physiology, and that
formation, not clearance, accounts for their presence.Materials and methods
Cells
Human blood was isolated in a protocol approved by the
Cleveland Clinic IRB. Human blood was drawn into acid-citrate-
dextrose and centrifuged (200g, 20 min) without braking to
obtain platelet-rich plasma. Platelets were stained with Annexin
V-Alex 488 (1/100 dilution) to measure surface phosphatidylser-
ine in binding buffer [140 mM NaCl, 10 mM Hepes (pH 7.4) and
2.5 mM CaCl2] for 15 min at room temperature. At the end of this
incubation the samples were diluted four-fold with binding buffer
and ﬂuorescence was assessed by ﬂow cytometry through the
Cleveland Clinic Flow core.
Mice (C57/Bl6) were used in a protocol approved by the
Cleveland Clinic’s IACUC to induce occlusive thrombosis as
described [12]. C57B/6 mice were anesthetized with ketamine
(90 mg/kg)/xylazine (15 mg/kg) and the right jugular vein and the
left carotid artery were exposed via a middle cervical incision.
Platelets were labeled in vivo by injecting 100 mL of rhodamine
6G (0.5 mg/ml) in saline into the right jugular vein 15 min before
FeCl3 injury. The left carotid artery was stripped of adventitia and
a piece of black plastic was placed under the vessel to reduce
background ﬂuorescence. A 12 mm2 piece of ﬁlter paper satu-
rated with 7.5% FeCl3 solution was applied to the carotid artery
for 1 min, the ﬁlter paper was removed, and the vessel rinsed
with saline. Fluorescent thrombus formation was observed in
real-time under a water immersion objective at 10 magniﬁca-
tion. Time to occlusive thrombosis was determined ofﬂine using
real time video image capture with a QImaging Retigo Exi 12-bit
mono digital camera (Surrey, Canada) and Streampix version
3.17.2 software (Norpix, Montreal, Canada). The end points were
set as either cessation of blood ﬂow for 430 s or no occlusion
after 30 min (three times longer than the average occlusion time),
in which case the time was recorded as 30 min for statistical
comparison.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.redox.2012.11.011.Mass spectrometry
Lipids were extracted [13] using [2H]PAF as an internal standard,
and then puriﬁed over an aminopropyl column [14] before being
quantiﬁed by liquid chromatography/electospray ionization/ tan-
dem mass spectrometry (LC/MS/MS) [15]. These analyses were
performed using a Quattro Ultima triple-quadrupole mass spectro-
meter (Micromass, Wythenshawe, UK) conﬁgured with the capillary
voltage at 5 kV, the cone voltage at 60 V, the source temperature at
120 1C, and a desolvation temperature at 250 1C. N2 and desolvation
gas ﬂow were 90 and 811 liters/h. Collision induced dissociation
used argon gas in a positive ion mode with multiple reaction
monitoring. The phosphocholine m/z 184 product ion is the domi-
nant ion of both PAF and Az-PC, and the precursor to product ion
transition was m/z 667-184 for Az-PC. The identity of Az-PC was
conﬁrmed in comparison with synthetic standards in the
negative mode.
In vivo phospholipid metabolism
[3H-acetyl]PAF in 0.5% albumin in PBS was injected into the
retro-orbital plexus. 100 mL Of blood was collected by cardiac
puncture, and intact [3H-acetyl]PAF was recovered by organic
extraction for quantitation by liquid scintillation counting.
Materials
Annexin V and rhodamine 6G was from Invitrogen (Carlsbad,
CA). [3H-acetyl]PAF was supplied by Perkin-Elmer (Boston, MA),
and [2H-acetyl]PAF and Az-PC from Cayman Chemical (Ann Arbor,
MI). Other reagents were from Sigma.
Expression of data and statistics
Experiments were performed at least three times, with assays
performed in triplicate. The standard errors of the mean from all
experiments are presented as error bars. Graphing of ﬁgures and
statistical analyses were generated with Prism4 (GraphPad Soft-
ware). A value of po0.05 was considered statistically signiﬁcant.Results
The oxidized phospholipid Az-PC is present in the circulation
of male mice at just over six times the amount circulating in
female C57/Bl6 mice (Fig. 1). There was little variation among
animals, reﬂected in a small standard error, so sex is a key
determinant of circulating Az-PC. This phospholipid is not a
product of cellular metabolism and is a prominent product of
phospholipid oxidation, so its presence signals prior phospholipid
oxidation. The phospholipid PAF also was more prominent in the
serum of male animals, although this difference was less than two
fold. PAF is thought to primarily reﬂect cellular production either
constitutively [16] or after stimulation of inﬂammatory cells [17],
but also is a product of phospholipid oxidation [18].
Circulating levels of Az-PC and PAF have been correlated with
the oxidative stress of ethanol catabolism [19], but also varied
with age. Young animals contained less of each phospholipid than
mice 10 weeks of age (Fig. 2), and again the difference was
greatest for Az-PC, 4-fold, relative to the 1.5 fold difference for
PAF abundance over the six week period of time.
PAF and Az-PC are cleared from the circulation not by hydro-
lysis, but rather by remarkably facile uptake into liver and kidney
so the half life of these two lipids in the circulation is far less than
a minute [11]. This rapid clearance did not depend on the sex of
the mice (Fig. 3A), nor did it depend on their age. The same rapid
Fig. 2. Circulating oxidized phospholipid and PAF are increased in older
animals. (A) AzPC and (B) C16-PAF levels in mice at age 4 or 10 weeks. C16-PAF
was more abundant than PAF containing an sn-1 C18 fatty ether residue (not
shown), as expected. Bars indicate average (7SD) of 5 mice per group. n Indicates
po0.05. Figures are a representative of two independent experiments.
Fig. 3. Clearance of circulating PAF is rapid, and independent of age or sex.
[3H-acetyl]PAF (10 mCi) in 100 mL of PBS containing 0.5% human serum albumin
was injected into (A) 12-week-old wild-type male (n¼5) or female (n¼5) mice, or
(B) wild-type male or female (8–12 weeks, n¼5 each group) through the retro-
orbital plexus. At the stated post-injection times, 100 mL of blood was collected by
cardiac puncture, and intact [3H-acetyl]PAF was recovered by organic extraction
for quantitation by liquid scintillation counting.
Fig. 1. Circulating phospholipids are increased in male mice. AzPC and PAF
levels in mice at 3 months of age were measured by mass spectrometry by
comparing the abundance of the m/z 184 phosphocholine transition peak from the
molecular ion of the sample phospholipid to the m/z 184 phosphocholine
transition peak from an [2H]PAF internal standard as described in Section 2.
Bars indicate average (7SD) of 5–10 mice n Indicates po0.05. Figures are a
representative of three independent experiments.
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females at 12 weeks, as it did in old female mice at 8 months of
age (Fig. 3B).
Platelets circulating in plasma will be exposed to Az-PC, and
this phospholipid depolarizes these anucleate cells [20] as it does
nucleated cells of the innate immune system [21,22]. Mainte-
nance of phospholipid asymmetry depends on the availability of
cellular energy, and Az-PC promoted phosphatidylserine expres-
sion on the surface of platelets (Fig. 4A). Platelet reactivity can be
assessed in vivo by determining the time it takes to form a
thrombus and stop blood ﬂow in a major vessel damaged by
ectopic FeCl3 oxidative damage [12,23]. Aging results in hyper-
sensitive platelets with a higher propensity to undergo thrombo-
sis where the time to occlusion fell from 11.2 min to 7.1 min as
male animals aged from 3 to 15 months. There was a signiﬁcant
decrease in older female animals as well where occlusive throm-
bosis took an average of 7.9 min after oxidative damage. The
slight difference between aged female and male animals itself
was not signiﬁcant.Discussion
Polyunsaturated fatty acids are esteriﬁed in phospholipids of
cellular membranes and circulating lipoproteins preferentially in
the sn-2 position of the glycerol backbone of the various phospho-
lipid classes. Polyunsaturated fatty acids are preferred oxidation
targets because the vinyl carbon–hydrogen bond between two
oleﬁnic bonds is weak [24]. Free radical attack and hydrogen
abstraction at these positions with bond rearrangement, if possible,
result in oxygen adduction at the beginning and end of a run of
double bonds. What this means in practice is that phospholipid
peroxides tend to reside at the ﬁrst or last carbon of the run
of double bonds. The 4, 5 bond of arachidonoyl or the 9, 10 bond
of esteriﬁed linoleoyl residues are therefore favored sites, and
Fig. 4. Platelets are depolarized by Az-PC, and occlusive platelet thrombosis is enhanced by aging. (A) Platelets exposed to Az-PC express phosphatidylserine on their
surface. Human platelets were treated with 10 mM Az-PC, or not, for 4 h before staining with Alexa488-conjugated Annexin V before ﬂow cytometry. (B) Time to thrombotic
occlusion of carotid arteries from WT C57/Bl6 male mice 3 months of age (n¼3) and WT male mice at 15 months (n¼4) and WT female also 15 months old (n¼5) was
measured after topical application of 7.5% FeCl3 to exposed carotid arteries as described in Section 2.
Fig. 5. Azelaoyl-phosphatidylcholine is generated from oxidative phospholipid
truncation. Phosphatidylcholine is the most abundant phospholipid of cellular
membranes, and is synthesized with two long chain fatty acyl residues esteriﬁed
to the sn-1 and sn-2 positions of the glycerol backbone. The sn-2 residues tend to
be both longer and with more unsaturation than the sn-1 residue. The most
common polyunsaturated fatty acyl residue is the C18:2 linoleoyl residue with two
oleﬁnic bonds between carbons 9,10 and 12, 13. Oxidation to a fatty acyl peroxyl
radical preferentially rearranges to the 9 or 13 carbon atom. This fatty acyl peroxyl
radical can fragment on either side of the newly introduced oxygen, so a common
oxidation product is a truncated phospholipid containing the 9-carbon azelaic acid
residue. This phospholipid is a product of oxidation, not physiologic anabolism.
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iﬁed linoleoyl residues, the 9-(hydro)peroxide is a common oxida-
tion product.
Lipid peroxides may fragment on either side of the oxygen
function, which for the common 9-(hydro)peroxide produces
either a 9-carbon fragment bearing the (hydro)peroxide at the
o-end of the shortened chain or, if fragmentation occurred on the
proximal side of the peroxide, an 8-carbon long fragment that
lacks the oxygen function. The trivial name for a 9-carbon
dicarboxylic fatty acid is azelaic acid, so oxidation of the most
common linoleoyl polyunsaturated fatty residue generates phos-
pholipids with sn-2 azelaoyl residues (Fig. 5). Accordingly, oxida-
tion of low density lipoprotein particles, which contain a shell of
phosphatidylcholine around a core of neutral cholesterol and
cholesterol esters, yields azelaoyl-phosphatidylcholine (Az-PC)
[25]. Intermediate length dicarboxylic fatty acids like azelaic acid
are not esteriﬁed into cellular phospholipids, so Az-PC is a marker
of oxidative stress, not cellular metabolism.
The phospholipids Az-PC and PAF slightly differ from one another
at the sn-1 position, where the bond in PAF is a carbon–oxygen–
carbon ether bond, compared to the ester bond of Az-PC. The largest
difference is the acetyl sn-2 residue of PAF compared to the 9-carbon
dicarboxy azelaoyl residue of Az-PC, but both are choline phospholi-
pids and both are reasonably soluble. Both are also transport sub-
strates for the phospholipid importer TMEM30a in mammalian cells
[11] and its ROS3 (also identiﬁed as LEM3 [26]) homolog in Sacchar-
omyces cerevisiae [27]. TMEM30a is expressed by endothelial cells and
labeled PAF and Az-PC both are rapidly cleared from the circulation by
transport as the intact molecule into liver and kidney [11].
The ﬂux of polar choline phospholipids out of the circulation is
one component of the balance of production and loss that deﬁnes
plasma phospholipid levels, but the rate of efﬂux from the
vascular compartment has not been examined to determine
whether it is variable. PAF and Az-PC are primarily products of
different systems, inﬂammation and oxidation, respectively, so
the increase in both lipids in the circulation of male and older
mice suggests their clearance mechanism would vary in common.
Instead, we found that under conditions where both Az-PC and
PAF were increased in the circulation that the rate of efﬂux was
fast, but remained constant. This implies the rate of PAF and
Az-PC production, that is oxidation and inﬂammation, are both
enhanced in older, male animals. That is, the continued ﬂux of
Az-PC shows both the male sex and age promote on-going
oxidative stress that is greater than in their counterparts.Oxidatively truncated phospholipids like Az-PC trafﬁc to mito-
chondria after internalization where they depolarize mitochondria
in a concentration dependent process [22]. Maintenance of phos-
pholipid asymmetry is energy dependent, so for platelets the
appearance of phosphatidylserine on their surface after loss of
mitochondrial function will promote tissue factor induced throm-
bin formation and thrombosis. This pro-thrombotic effect will be
enhanced in male animals with increased numbers of circulating
platelets.
Platelet function can be assessed in vivo by oxidatively dama-
ging carotid arteries by brieﬂy applying FeCl3 to the external
J. Liu et al. / Redox Biology 1 (2013) 110–114114aspect of the closed, intact vessel. The ﬂow of platelets, previously
labeled with ﬂuorescent rhodamine dye can be assessed by video
microscopy, their accretion at the site of damage can be imaged,
and the time it takes before blood ﬂow is abolished by formation
of an occlusive platelet thrombus can be quantiﬁed. We found
that aging greatly increased the rapidity of occlusive thrombus
formation.
Overall, we found that oxidized phospholipid increases in the
circulation during normal physiologic process of aging and is
increased in male animals. We also discovered that the rate of
clearance of these markers of chemical oxidation and for inﬂam-
matory PAF was invariant, so the relative abundance of polar
choline phospholipids reﬂects their relative rates of generation
and introduction to the circulation. Circulating Az-PC is thus a
systemic marker of continual oxidative attack on cellular phos-
pholipids. Its rapid clearance means it reports this oxidation in
real time. We therefore document a continual and enhanced
oxidative attack on the cellular phospholipids of older, male
animals.Contribution of authors
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